top of page

Understanding Treatment Resistant Depression Causes, Treatments, and Hope

Writer: Drsimon Psychiatry
Drsimon Psychiatry
5 days ago
8 min read

For many people with depression, the hardest sentence to say is, “I am doing everything I was told to do, and I still do not feel better.”


That experience can be frightening and lonely. Medication may have been taken as prescribed. Therapy appointments may have been kept. Sleep, work, family, and daily routines may still feel heavy. When depression does not improve after standard care, clinicians may begin to consider treatment-resistant depression, often shortened to TRD.


TRD does not mean someone is “beyond help”. It means the first treatments have not worked well enough, and the care plan needs to become more precise, layered, and closely supported.


This article is for general information only and is not a substitute for medical advice. Depression can be serious. If there is a risk of self-harm, suicide, or harm to others, seek urgent help through local emergency services or the nearest hospital emergency department.


Eye-level view of a person sitting quietly by a window with a warm drink
Depression that does not lift can feel isolating, but it can still be treated.

What treatment-resistant depression means


Depression is usually diagnosed through symptoms such as low mood, loss of interest, changes in sleep or appetite, low energy, guilt, poor concentration, and thoughts of death or self-harm. Standard treatment often includes antidepressant medication, psychotherapy, or both.


Treatment-resistant depression is commonly defined as depression that has not improved enough after at least two adequate trials of antidepressant treatment. “Adequate” matters. It usually means:


  • The medication was suitable for the diagnosis

  • The dose was high enough to have a real chance of working

  • It was taken consistently

  • It was used for long enough, often several weeks or more

  • Side effects and interactions were reviewed


Some people improve only slightly. Others feel no change at all. Some feel better for a short time and then relapse.


TRD is not rare. Research commonly suggests that a sizeable minority of people with major depressive disorder do not reach remission after first-line treatment. Many estimates place this group at around one-third of patients, though the exact number varies depending on how TRD is defined and studied.


The main point is simple: if depression has not responded to the first or second treatment, the person is not failing. The illness may need a different approach.


Why some depression does not respond to standard treatment


There is no single reason why treatment may not work. Depression is not one uniform condition. It can involve different brain circuits, stress systems, immune signals, genetics, trauma histories, vulnerabilities, and psychosocial pressures.


The diagnosis may need another look


Sometimes the depression diagnosis is correct, but incomplete. A person may also have:


  • Bipolar disorder, where antidepressants alone may be less effective or may worsen mood cycling

  • Anxiety disorders, panic attacks, obsessive-compulsive symptoms, or post-traumatic stress

  • Substance use concerns, including alcohol or sedative use

  • ADHD, eating disorders, or personality-related patterns

  • Chronic pain or long-term medical conditions


This does not mean the original diagnosis was careless. Symptoms can unfold over time. A careful reassessment can change the treatment plan in a useful way.


The treatment may not have had a fair trial


Antidepressants can take time. Side effects may appear before benefits. Some people stop early because they feel worse, numb, restless, nauseated, or emotionally flat.


Other times, the dose is too low, the medication is taken irregularly, or another medicine reduces its effect. Cost, stigma, transport, shift work, family duties, and fear of side effects can also interrupt care.


When there is no blame in the conversation, these details become easier to talk about.


Biology and genetics can influence response


People metabolise medicines differently. Some break down certain antidepressants quickly, leaving too little active medicine in the body. Others process them slowly and get more side effects.


Family history can offer clues. If a parent or sibling responded well to a certain medicine, that may guide a clinician. It is not a guarantee, but it can help.


Life stress can keep the nervous system under strain


Medication can help brain chemistry, but it cannot remove an unsafe home, financial pressure, grief, loneliness, school pressures, workplace bullying, caregiving exhaustion, or unresolved trauma.


This does not make depression “situational” in a dismissive sense. It means the brain and body respond to the conditions around them. A good treatment plan looks at both biology and life context.


A more complete assessment can change the path


Before labelling depression as resistant, clinicians usually review the full picture. This may include:


  • Current and past medication trials

  • Dose, duration, benefit, and side effects

  • Therapy history and what type of therapy was used

  • Sleep quality, including possible sleep apnoea

  • Thyroid disease, anaemia, vitamin deficiencies, chronic pain, and hormonal factors

  • Alcohol, cannabis, stimulant, or sedative use

  • Suicide risk and safety planning

  • Family history of mood disorders

  • Past episodes of mania or hypomania


A useful question is not only, “What treatment failed?” It is also, “What has not yet been tried in the right way?”


Medication strategies that may help


Medication remains an important tool for many people with TRD. The next step is usually not random switching. It is a structured plan based on the person’s symptoms, past response, side effects, medical history, and preferences.


Switching antidepressants


If one antidepressant has not helped, a clinician may recommend switching to another. This can mean moving within the same class, such as from one SSRI to another, or changing to a different class, such as an SNRI, mirtazapine, bupropion where available, or a multimodal antidepressant.


A careful switch matters because stopping suddenly can cause withdrawal symptoms or relapse. Some medicines also interact if overlapped incorrectly.


Augmentation of medications


Augmentation means adding another medicine to support the antidepressant effect. This is common in TRD care.


Options may include:


  • Atypical antipsychotic medicines at low doses

  • Lithium/Lamotrigine in selected cases

  • Neuromodulation therapy in certain patients

  • Another antidepressant with a different action

  • Medicines that target sleep, anxiety, or agitation when these symptoms block recovery


Augmentation should always be monitored. Benefits need to be weighed against side effects such as weight change, sedation, metabolic changes, tremor, or blood test abnormalities.


Esketamine therapy


Esketamine is one of the more discussed evidence-based treatments for treatment-resistant depression. It is related to ketamine and is given as a nasal spray in medically supervised settings in countries where it is approved and available.


Unlike traditional antidepressants, which often work mainly through serotonin, noradrenaline, or dopamine pathways, esketamine acts on the glutamate system. Research suggests it can reduce depressive symptoms in some people with TRD, sometimes more quickly than standard antidepressants.


Esketamine is not a casual treatment. It usually requires:


  • Careful screening

  • Use alongside an oral antidepressant in many protocols

  • Monitoring after each dose

  • Blood pressure checks

  • Observation for dissociation, dizziness, sedation, or nausea

  • A structured treatment schedule


It may not be suitable for people with certain medical histories. Access, cost, and local regulations also vary. Still, for some patients who have tried several treatments without enough relief, Esketamine can be a meaningful option to discuss with a psychiatrist.


Neuromodulation can target brain circuits in a different way


Neuromodulation treatments use electrical or magnetic stimulation to influence brain activity. They are usually considered when medication and therapy have not brought enough improvement, or when symptoms are severe.


Repetitive transcranial magnetic stimulation


Repetitive transcranial magnetic stimulation, often called rTMS, uses magnetic pulses applied to specific areas of the head. It does not require anaesthesia, and many people continue normal activities after sessions.


A course usually involves repeated sessions over several weeks. Side effects are often mild, such as scalp discomfort or headache, though suitability must be assessed by a trained clinician.


rTMS may appeal to people who have not tolerated medication side effects or who want a non-medication option as part of their care plan.



Other forms of stimulation


Other approaches, such as vagus nerve stimulation or deep brain stimulation, may be used in specific settings or research contexts. These are not first-line options for most patients, but they show how TRD care continues to develop.


Close-up of a hand holding a journal beside medication and a glass of water
Tracking symptoms and treatments can help clinicians see patterns more clearly.

Psychotherapy still matters when medication has not worked enough


When depression is labelled treatment-resistant, therapy can still play a major role. The key is matching the therapy to the person’s needs.


Cognitive behavioural therapy can help identify patterns that keep depression active, such as withdrawal, self-criticism, and hopeless predictions. Behavioural activation focuses on rebuilding activity in small steps, even before motivation returns.


Other therapies may help with specific roots of depression:


  • Trauma-focused therapy for unresolved trauma

  • Interpersonal therapy for grief, role changes, or relationship stress

  • Acceptance and commitment therapy for living with painful thoughts without being ruled by them

  • Family or couples therapy when home dynamics affect recovery


Therapy does not mean “thinking positive”. It can offer skills, structure, and a place to be honest without being judged.


Complementary approaches and lifestyle changes can support recovery


Lifestyle changes are not a cure-all. Telling someone with severe depression to “exercise and sleep better” can feel dismissive. Yet when used kindly and realistically, daily habits can support medical treatment.


Useful areas to review include:


  • Sleep A regular sleep-wake pattern can stabilise mood. Sleep apnoea, insomnia, and shift work may need specific treatment.


  • Movement Gentle walking, stretching, swimming, or supervised exercise can help mood and energy. The goal is consistency, not intensity.


  • Food and hydration Regular meals can reduce mood dips. Some people benefit from support around appetite loss, binge eating, or restrictive eating.


  • Sunlight and routine Morning light and predictable routines can help the body clock, especially when depression causes long hours in bed.


  • Social contact Recovery often starts with low-pressure contact, such as sitting with a family member, joining a support group, or sending one message.


  • Mindfulness and relaxation Breathing exercises, prayer, meditation, grounding skills, massage, or yoga may reduce stress for some people.


Complementary therapies should not replace evidence-based care, especially when depression is moderate to severe. Supplements and herbal products can also interact with medication, so they should be discussed with a clinician.


Case stories show what hope can look like


The following examples are fictional composites based on common clinical situations. They do not describe real individuals.


Aina found the missing diagnosis


Aina, 34, had tried two antidepressants. Each helped for a few weeks, then her mood crashed. She blamed herself and wondered if she was “too difficult to treat”.


During a reassessment, her psychiatrist asked more detailed questions about past periods of high energy, little sleep, impulsive spending, and racing thoughts. Aina had never mentioned them because they felt like “good weeks” compared with depression.


Her diagnosis changed to bipolar depression. Her care plan shifted away from antidepressant-only treatment and included a mood stabiliser, sleep protection, and therapy focused on recognising early warning signs.


The change was not instant, but it made sense of years of confusion. Aina stopped seeing herself as a failure and started seeing a pattern that could be treated.


Daniel needed a layered plan


Daniel, 48, had depression after a long period of work stress and chronic back pain. He tried medication, but fatigue and pain kept him in bed. Therapy felt impossible because he could not concentrate.


His doctor reviewed his pain medicines, screened for sleep problems, and adjusted his antidepressant. A psychiatrist added an augmentation medicine. Daniel also began short behavioural activation sessions. His first goal was not “be happy”. It was to shower before noon three days a week and walk to the gate once a day.


Later, he started rTMS. After several weeks, his family noticed he was speaking more and eating dinner with them again. Daniel still had hard days, but his life was no longer shrinking every week.



What helps when the road feels long


Living with TRD can make time feel heavy. Progress may come in small changes before a person feels “well”. Getting out of bed a little earlier, crying less often, answering a message, or feeling one moment of interest can all be signs that something is shifting.


A practical plan often includes:


  • A written list of past treatments, doses, side effects, and response

  • One main clinician coordinating care where possible

  • Regular review of suicide risk and safety steps

  • Involvement of selected family or trusted friends, with consent

  • Clear goals that are small enough to repeat

  • A relapse plan for early warning signs


Hope in TRD is not blind optimism. It is the recognition that depression has many treatment paths, and not all of them may have been tried yet.


There is still a way forward


Treatment-resistant depression can be exhausting, but it is not the end of the story. It is a signal to reassess, refine the diagnosis, review past treatments, and consider a broader plan.


For some people, the next step is a different antidepressant. For others, it is augmentation, esketamine therapy, neuromodulation, trauma-focused therapy, better sleep treatment, or support for pain, grief, or substance use. Often, recovery comes from combining several of these rather than relying on one answer.


The most helpful message is also the simplest: needing more treatment does not mean someone is weak. It means the depression is complex, and complex conditions deserve careful, compassionate care.


 
 
 

Comments


bottom of page